Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Orbimed Advisors LLC's stake in Lexeo Therapeutics, Inc. fell to 3.90% (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Orbimed Advisors LLC's stake in Lexeo Therapeutics, Inc. fell to 3.90%, 3,203,050 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 3.90%
- Shares
- 3,203,050
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| OrbiMed Advisors LLC | 3.90% | 3,203,050 |
| OrbiMed Capital LLC | 0% | 0 |
Source
Download original · View original at SEC
Related
- Lexeo Therapeutics, Inc.
- Orbimed Advisors LLC
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G · Orbimed Advisors LLC · Aug 14, 2026
- Form 4 · Tamayo Louis Edward · Nov 18, 2026
- Form 4 · Otero Jose Manuel · Nov 18, 2026
- Form 4 · Townsend Richard Nolan · Nov 18, 2026
- Schedule 13G/A · Paradigm Biocapital Advisors LP · Nov 16, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Nov 16, 2026